Parallax Volatility Advisers
GMED icon

Parallax Volatility Advisers’s Globus Medical GMED Stock Holding History

Parallax Volatility Advisers’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,310
Closed -$114K – 2973
2020
Q3 		$114K Buy
2,310
+2,127
+1,162% +$110K ﹤0.01% 2694
2020
Q2 		$9K Buy
183
+167
+1,044% +$8.06K ﹤0.01% 2618
2020
Q1 		$1K Buy
+16
New +$790 ﹤0.01% 2408
2018
Q4 		– Sell
-51
Closed -$3K – 3289
2018
Q3 		$3K Hold
51
– – ﹤0.01% 2372
2018
Q2 		$3K Sell
51
-264
-84% -$13.8K ﹤0.01% 1877
2018
Q1 		$16K Sell
315
-10,527
-97% -$495K ﹤0.01% 1742
2017
Q4 		$446K Buy
10,842
+505
+5% +$17.7K ﹤0.01% 1627
2017
Q3 		$307K Buy
+10,337
New +$316K ﹤0.01% 1363

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Parallax Volatility Advisers's GMED Position: Q4 2020 in Review

Parallax Volatility Advisers sold out of Globus Medical (GMED) in Q4 2020, closing a stake of 2,310 shares — an estimated $114K sold.

Parallax Volatility Advisers first reported a position in GMED in Q3 2017 and held it in 8 quarters. The position peaked at $446K in Q4 2017. 348 funds tracked by Wall St. Rank hold GMED as of Q4 2020.

  • Parallax Volatility Advisers reported no remaining Globus Medical position as of Q4 2020 after selling out during the quarter.
  • Parallax Volatility Advisers sold 2,310 Globus Medical shares in Q4 2020, an estimated $114K.
  • Parallax Volatility Advisers first reported a position in Globus Medical in Q3 2017 and held it in 8 quarters.
  • Parallax Volatility Advisers's Globus Medical position peaked at $446K in Q4 2017.
  • 348 funds tracked by Wall St. Rank held Globus Medical as of Q4 2020.

Based on Parallax Volatility Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.